We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$840B
AUM Growth
-$11.4B
Cap. Flow
+$21.2B
Cap. Flow %
2.53%
Top 10 Hldgs %
26.02%
Holding
4,905
New
147
Increased
3,717
Reduced
626
Closed
142

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.02B
2
AAPL icon
Apple
AAPL
+$837M
3
AMZN icon
Amazon
AMZN
+$811M
4
KVUE icon
Kenvue
KVUE
+$761M
5
BX icon
Blackstone
BX
+$581M

Sector Composition

Rank Sector Weight
1 Technology 27.7%
2 Healthcare 13.07%
3 Financials 12.46%
4 Consumer Discretionary 10.84%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORMP icon
4401
Oramed Pharmaceuticals
ORMP
$167M
$54.6K ﹤0.01%
20,909
MIST icon
4402
Milestone Pharmaceuticals
MIST
$138M
$54.5K ﹤0.01%
17,576
TRVN
4403
DELISTED
Trevena, Inc.
TRVN
$53.9K ﹤0.01%
3,570
+963
+37% +$20.8K
XBIO icon
4404
Xenetic Biosciences
XBIO
$5.81M
$53.8K ﹤0.01%
+10,998
New +$45.9K
MARK
4405
DELISTED
Remark Holdings, Inc.
MARK
$53.4K ﹤0.01%
106,981
+17,788
+20% +$13.6K
CRVO icon
4406
CervoMed
CRVO
$23.9M
$52.9K ﹤0.01%
11,092
-323
-3% -$1.63K
LSF icon
4407
Laird Superfood
LSF
$45.8M
$52.9K ﹤0.01%
51,333
+17,886
+53% +$19.2K
VEEE icon
4408
Twin Vee PowerCats
VEEE
$6.68M
$52.8K ﹤0.01%
100
OLB icon
4409
OLB
OLB
$4.28M
$52.3K ﹤0.01%
7,176
-198
-3% -$1.54K
NXU
4410
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$52.1K ﹤0.01%
88
+17
+24% +$17.4K
ENSV
4411
DELISTED
Enservco Corp.
ENSV
$52.1K ﹤0.01%
136,660
+29,531
+28% +$10.9K
SOPA
4412
DELISTED
Society Pass
SOPA
$52.1K ﹤0.01%
9,154
+1,913
+26% +$13.3K
BLIN icon
4413
Bridgeline Digital
BLIN
$14.6M
$52K ﹤0.01%
62,513
+20,112
+47% +$20.6K
EBET
4414
DELISTED
EBET, INC. Common Stock
EBET
$51.7K ﹤0.01%
33,266
+30,592
+1,144% +$61.8K
VRPX
4415
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$51.2K ﹤0.01%
256
-8
-3% -$1.76K
ERNA icon
4416
Eterna Therapeutics
ERNA
$3.83M
$50.9K ﹤0.01%
60
+23
+62% +$21.2K
APLM icon
4417
Apollomics
APLM
$37.9M
$50.3K ﹤0.01%
134
NCNC
4418
DELISTED
noco-noco Inc. Ordinary Share
NCNC
$50.2K ﹤0.01%
+42,561
New +$54.1K
KUST
4419
Kustom Entertainment Inc
KUST
$777K
$50.2K ﹤0.01%
1
SJ icon
4420
Scienjoy Holding
SJ
$43.7M
$50.1K ﹤0.01%
17,909
PULM icon
4421
Pulmatrix
PULM
$6.35M
$50.1K ﹤0.01%
24,660
+36
+0.1% +$89
CBAT icon
4422
CBAK Energy Technology Ltd
CBAT
$44.3M
$49.2K ﹤0.01%
60,126
LABP
4423
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$48.8K ﹤0.01%
+12,604
New +$49.2K
CREX icon
4424
Creative Realities
CREX
$41.1M
$48.6K ﹤0.01%
30,540
-37,722
-55% -$95.1K
MAPS
4425
DELISTED
WM TECHNOLOGY INC A
MAPS
$48.6K ﹤0.01%
36,578
+597
+2% +$719

Similar funds

Geode Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
  • Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
  • Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
  • Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
  • Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
  • Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
  • Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.